Both in Pharmaceuticals
Neuphoria Therapeutics vs Marker Therapeutics
Over the past year NEUP returned −30.7% and MRKR returned −0.8%; their daily moves had a correlation of 0.18.
NEUP −30.7% MRKR −0.8%Growth of $1, one year, split-adjusted
| Metric | NEUP | MRKR |
|---|---|---|
| Price | $3.05 | $0.9800 |
| Market cap | $16.5M | $16.3M |
| Today | −0.33% | −2.97% |
| 1 month | −13.1% | −6.7% |
| 6 months | −41.6% | −32.9% |
| Year to date | −21.4% | −34.2% |
| 1 year | −33.4% | +1.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 7.0× |
| Net cash | — | $11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 28.0% | 82.2% |
| Short % of float | 0.1% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).